Please Wait...

LitTrace

Literature Monitoring Tool

LitTrace is a customizable literature monitoring and tracking tool that ensures timely access to reliable and consolidated information on relevant safety-related literature and creates databases for ICSR's and similar compliance reports.

LitTrace can be used to monitor literature relating to:

  • Clinical evaluation
  • Pre-market approval
  • Adverse events reporting

Benefits of LitTrace include:

  • Fully customizable – per client's unique requirements
  • Flexible folder structure – build multiple folders based on product or therapeutics areas (including subfolders)
  • Import third party data – EMBASE, MEDLINE, etc.
  • Simple, easy-to-use tool – for assessment workflow tracking
  • Configurable reporting engine
  • Flexible delivery options – client environment or Bioclinica hosted
  • Central repository – for weekly hits and full-text articles
  • One-stop solution to track full-text article – translation and contract author requests preparation and compliance as required by the FDA, EMEA and other global regulatory bodies
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @MdFacep: FDA approvals: Merck's Keytruda wins FDA approval as combination therapy for kidney cancer. BIG! https://t.co/LgCzL1mvaF @Reu…
Bioclinica (8 hours ago)
RT @FDA_Drug_Info: National Prescription Drug Take Back Day is April 27, 2019 from 10:00 AM to 2:00 PM. Learn how to dispose of unused and…
Bioclinica (8 hours ago)
RT @iofbonehealth: #Osteoporosis Int: Spanish National Hip Fracture Registry (RNFC): analysis of its first annual report and international…
Bioclinica (8 hours ago)
RT @HINJ_ORG: New Jersey's biopharmaceutical industry: CIANJ has assembled a panel of industry leaders @Celgene, @Bayer & @PhRMA to discuss…
Bioclinica (8 hours ago)
RT @PhRMA: Last year, the top 15 largest biopharmaceutical companies spent more than $100 billion on R&D, according to @IQVIA_global. More…
Bioclinica (8 hours ago)
RT @SCDM_DataDriven: Registrations for the SCDM 2019 Annual Conference are now open!! #SCDM2019 Register now for the biggest event in the…
Bioclinica (8 hours ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box